Collectively, these results demonstrate that LCN2 attenuates NF‐κB pathway activation by inhibiting K63‐ and M1‐linked ubiquitination of NEMO in an ANXA1‐dependent manner, thereby downregulating CCL5 expression in GC cells. This evidence concerns the gene LCN2 and gastric cancer.